| View |
|
DR-XY44958
|
Letrozole
|
Letvex
|
2.5mg
|
Film Coated Tablet
|
-
|
ADMAC Lifesciences
|
India
|
-
|
08 February 2021
|
21 December 2025
|
| View |
|
DR-XY44960
|
Sulodexide
|
Angioflux
|
250 LSU
|
Softgel Capsule
|
-
|
Catalent Italy S.P.A.
|
Italy
|
Automatic Renewal (Reconstruction)
|
23 August 2022
|
28 December 2025
|
| View |
|
DR-XY44961
|
Ceftriaxone (As Sodium)
|
Nirixone
|
1 g
|
Powder For Inj.
|
ANTIBACTERIAL
|
Aculife Healthcare Private Limited
|
India
|
Automatic Renewal
|
14 December 2022
|
28 December 2027
|
| View |
|
DR-XY44964
|
Rosuvastatin (As Calcium)
|
Rovex 20
|
20mg
|
Film Coated Tablet
|
-
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
-
|
12 April 2021
|
05 January 2026
|
| View |
|
DR-XY44965
|
Oenothea biennis + Lecithin + Methionin + brewer's yeast + Taraxacum Officinale Wigg. + Apple Cide Vinegar + Choline + Inositol + Selenium
|
Detoc
|
300 mg/ 100 mg/ 100mg/ 50 mg/ 50 mg/ 50 mg/ 50 mg/ 50 mg/ 70 mcg
|
Capsule
|
-
|
Mega Lifesciences Ltd.
|
Thailand
|
-
|
10 August 2020
|
25 December 2025
|
| View |
|
DR-XY44966
|
Multivitamins + Zinc + Copper
|
Clusivol Plus
|
See Reverse formulation
|
Film-Coated Tablet
|
-
|
Pfizer Biotech Corporation, (Hsinchu Plant)
|
China
|
Automatic Renewal
|
10 December 2020
|
21 December 2025
|
| View |
|
DR-XY44968
|
Amino Acids
|
Minosol-5%
|
50 mg/mL (5% w/v)
|
Solution For Iv Infusion
|
-
|
Jiangsu Pengyao Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
21 October 2020
|
21 September 2025
|
| View |
DR-XY44970_PI_01.pdf
|
DR-XY44970
|
Dapagliflozin (as propanediol monohydrate) +
Metformin Hydrochloride
|
Xigduo XR
|
5 mg/500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
AstraZeneca Pharmaceuticals LP
|
U.S.A
|
Initial (from Monitored Release status)
|
05 April 2024
|
05 January 2029
|
| View |
DR-XY44971_PI_01.pdf
|
DR-XY44971
|
Dapagliflozin (as propanediol monohydrate) +
Metformin Hydrochloride
|
Xigduo XR
|
5 mg/1000 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
AstraZeneca Pharmaceuticals LP
|
U.S.A
|
Initial (from Monitored Release status)
|
05 April 2024
|
05 January 2029
|
| View |
DR-XY44972_PI_01.pdf
|
DR-XY44972
|
Dapagliflozin (as propanediol monohydrate) +
Metformin Hydrochloride
|
Xigduo XR
|
10 mg/500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
AstraZeneca Pharmaceuticals LP
|
U.S.A
|
Initial (from Monitored Release status)
|
05 April 2024
|
05 January 2029
|
| View |
DR-XY44973_PI_01.pdf
|
DR-XY44973
|
Dapagliflozin (as propanediol monohydrate) +
Metformin Hydrochloride
|
Xigduo XR
|
10 mg/1000 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic.
|
AstraZeneca Pharmaceuticals LP
|
U.S.A
|
Initial (from Monitored Release status)
:
|
05 April 2024
|
05 January 2029
|
| View |
DR-XY44976_PI_01.pdf
|
DR-XY44976
|
Perindopril Arginine + Indapamide + Amlodipine (as
besilate)
|
Triplixam
|
5 mg/ 1.25 mg/ 5 mg
|
Film-Coated Tablet
|
Antihypertensive (ACE Inhibitor-Diuretic-Calcium
Channel Blocker Combination)
|
Servier (Ireland) Industries Ltd.
|
Ireland
|
Initial (from Monitored Release status) :
|
29 April 2022
|
29 December 2025
|
| View |
DR-XY44977_PI_01.pdf
|
DR-XY44977
|
Perindopril Arginine + Indapamide + Amlodipine (As Besilate)
|
Triplixam
|
5mg/1.25mg/10mg
|
Film-Coated Tablet
|
Antihypertensive (ACE Inhibitor-Diuretic-Calcium Channel Blocker Combination)
|
Servier (Ireland) Industries, Ltd.
|
Ireland
|
Initial (from Monitored Release)
|
24 May 2022
|
29 December 2025
|
| View |
DR-XY44979_PI_01.pdf
|
DR-XY44979
|
Perindopril arginine + Indapamide + Amlodipine (as
besilate)
|
Triplixam
|
10 mg/2.5 mg/10 mg
|
Film-Coated Tablet
|
Antihypertensive (ACE Inhibitor-Diuretic-Calcium
Channel Blocker Combination)
|
Servier (Ireland) Industries, Ltd.
|
Ireland
|
Initial [from Monitored Release]
|
30 May 2022
|
29 December 2025
|
| View |
|
DR-XY44983
|
Multivitamins + Minerals
|
Centrum Silver Advance
|
|
Film Coated Tablet
|
Vitamins and Minerals
|
Wyeth Pharmaceutical Co. Ltd.
|
China
|
Automatic Renewal
|
03 March 2022
|
12 May 2026
|
| View |
|
DR-XY44984
|
Cilostazol
|
Cilostan CR
|
200 mg
|
Controlled-Release Tablet
|
-
|
Korea United Pharm. Inc.
|
Korea
|
Initial (from Monitored release)
|
01 September 2022
|
19 January 2026
|
| View |
DR-XY44985_PI_01.pdf
|
DR-XY44985
|
Tadalafil
|
Cialis
|
20 mg
|
Film-Coated Tablet
|
-
|
Lilly del Caribe, Inc.
|
Puerto Rico
|
Monitored Release (MR) to Initial
|
09 May 2023
|
14 January 2026
|
| View |
|
DR-XY44987
|
Octocaine 100
|
Lidocaine Hydrochloride + Epinephrine (As Bitartrate)
|
20 mg/10 mcg per mL
|
Solution for Injection (Oromucosal)
|
-
|
Novocol Pharmaceutical of Canada Inc.
|
Canada
|
-
|
19 May 2021
|
13 January 2026
|
| View |
|
DR-XY44988
|
Articaine Hydrochloride + Epinephrine (as bitartrate)
|
Posicaine 200
|
40 mg/5 mcg per mL
|
Solution for Injection (Oromucosal)
|
-
|
Novocol Pharmaceutical of Canada Inc.
|
Canada
|
-
|
25 March 2022
|
13 January 2026
|
| View |
|
DR-XY44989
|
Mepivacaine Hydrochloride
|
Isocaine 3%
|
30 mg/ mL
|
Solution For Injection (Oromucosal)
|
-
|
Novocol Pharmaceutical of Canada Inc.
|
Canada
|
-
|
21 March 2022
|
13 January 2026
|